Oral Solids Manufacturing

Nagoya Site

The manufacturing site in Nagoya, Japan offers specialized expertise in complex oral solids with capabilities of developing unique formulation such as ODT (orally disintegrating tablet). This site has a range of manufacturing capabilities including a dedicated facility for high contained products as well as delivery and digital technologies. Available services include dosage form flexibility, producing low dose, single and dual dosage forms, combination products and immediate or extended released.

Learn more about Pfizer Nagoya

About Nagoya

High adaptability for detailed request from Japanese market, based on 50 years experience

61 acre campus ~ 90,000m2 facility

Employs 700+ colleagues